Middle East and Africa Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2026
Short Description
By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Country (South Africa, South Arabia, UAE, Kuwait, Rest of Middle East & Africa)
Market Definition:
Drug safety and pharmacovigilance can be well-defined as the science and activities associated with the detection, assessment, understanding and preclusion of antagonistic drug action or any other adverse drug reactions. Pharmacovigilance (PV) as defined by the European Commission (EU) is the “process and science of observing the safety of drugs and taking action to minimize the adverse drug reactions and increase the benefits of medicines”.
Drug Safety and Pharmacovigilance can be beneficial in the various assessments such as medication errors, adverse interactions of medicines with chemicals, other medicines, and food, public health and safety in relation to the use of medicines, case reports of acute and chronic poisoning, abuse and misuse of medicines and others.
Market Segmentation:
Middle East and Africa drug safety solutions and pharmacovigilance market is segmented into three notable segments which are type, end user and distribution channel.
• On the basis of type, the market is segmented into software and services
• On the basis of end user, the market is segmented into hospitals, healthcare providers, pharmaceutical & biotechnology industries, KPOs/BPOs, contract research organizations (CROS) and others
• On the basis of distribution channel, the market is segmented into direct sales and retail sales
Market Players
The key market players for Middle East and Africa drug safety solutions and pharmacovigilance market are listed below:
• Pharmaceutical Product Development, LLC
• Drug Safety Solutions Limited
• C3i
• Worldwide Clinical Trials
• Bioclinica
• United Biosource LLC
• Ennov
• AB Cube
• Covance Inc.
• Accenture
• PRA Health Sciences, Inc.
• Ergomed
• IQVIA
• Genpact
• Cognizant
• Parexel International Corporation
• ArisGlobal
• ICON plc
• Oracle
• Syneos Health
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Middle East And Africa Drug Safety Solutions & Pharmacovigilance Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Primary Interviews With Key Opinion Leaders
- 2.8 Dbmr Market Position Grid
- 2.9 Vendor Share Analysis
- 2.10 Secondary Sources
- 2.11 Assumptions
- 3 Market Overview
- 3.1 Drivers
- 3.1.1 Increasing Number Of Clinical Trials
- 3.1.2 Growing Number Of Contract Research Organizations
- 3.1.3 Increase In R & D Expenditure By Pharmaceutical And Biopharmaceutical Companies
- 3.1.4 Increase In The Number Of Adverse Drug Reactions (Adrs)
- 3.2 Restraint
- 3.2.1 High Cost Of Drug Safety Solutions & Pharmacovigilance
- 3.3 Opportunities
- 3.3.1 Automation In Drug Safety Solutions & Pharmacovigilance
- 3.3.2 Research Collaborations And Partnerships
- 3.3.3 Strategic Initiatives By Market Players
- 3.4 Challenge
- 3.4.1 The Misreporting And Miscoding Of Adverse Events
- 4 Executive Summary
- 5 Middle East And Africa Drug Safety Solutions & Pharmacovigilance Market, By Type
- 5.1 Overview
- 5.2 Software
- 5.2.1 Adverse Event Reporting Software
- 5.2.1.1 On-premise
- 5.2.1.2 Cloud Based
- 5.2.2 Drug Safety Audits Software
- 5.2.2.1 On-premise
- 5.2.2.2 Cloud Based
- 5.2.3 Data Management Software
- 5.2.3.1 On-premise
- 5.2.3.2 Cloud Based
- 5.2.4 Fully Integrated Software
- 5.2.4.1 On-premise
- 5.2.4.2 Cloud Based
- 5.2.5 Issue Tracking Software
- 5.2.5.1 On-premise
- 5.2.5.2 Cloud Based
- 5.2.6 Clinical Trial Management Solution
- 5.2.6.1 On-premise
- 5.2.6.2 Cloud Based
- 5.2.7 Regulatory Content And Information Management Software
- 5.2.7.1 On-premise
- 5.2.7.2 Cloud Based
- 5.2.8 Medical Affairs Software
- 5.2.8.1 On-premise
- 5.2.8.2 Cloud Based
- 5.2.9 Others
- 5.2.9.1 On-premise
- 5.2.9.2 Cloud Based
- 5.3 Services
- 5.3.1 Clinical Data Management
- 5.3.1.1 Data Entry And Case Processing
- 5.3.1.2 Clinical Trial Monitoring
- 5.3.1.3 Clinical Trial Safety Submissions
- 5.3.1.4 Case Processing (Saes)
- 5.3.1.5 Others
- 5.3.2 Drug Safety Solutions
- 5.3.2.1 Quality And Medical Review
- 5.3.2.2 Literature And Social Media Monitoring
- 5.3.2.3 Safety Database
- 5.3.2.4 Individual Case Study Report
- 5.3.2.5 Periodic Reports
- 5.3.2.6 Medical Literature Search
- 5.3.2.7 Signal Detection
- 5.3.2.8 Expedited Reports
- 5.3.2.9 Others
- 5.3.3 Aggregate Safety Reporting
- 5.3.4 Regulatory Services
- 5.3.4.1 Safety Regulatory Submissions
- 5.3.4.2 Post-marketing Surveillance
- 5.3.4.3 Medical Device Vigilance
- 5.3.4.4 Regulatory Consulting
- 5.3.4.5 Others
- 5.3.5 Risk Management Services
- 5.3.6 Medical Information Call Center Services
- 5.3.7 Audit Services
- 5.3.8 Training Support Services
- 5.3.9 Others
- 6 Middle East And Africa Drug Safety Solutions & Pharmacovigilance Market, By End Users
- 6.1 Overview
- 6.2 Pharmaceutical & Biotechnology Industries
- 6.3 Contract Research Organizations (Cros)
- 6.4 Hospitals
- 6.5 Kpos/Bpos
- 6.6 Healthcare Providers
- 6.7 Others
- 7 Middle East And Africa Drug Safety Solutions & Pharmacovigilance Market, By Distribution Channel
- 7.1 Overview
- 7.2 Direct Sales
- 7.3 Retail Sales
- 8 Middle East And Africa Drug Safety Solutions & Pharmacovigilance Market, By Geography
- 8.1 Middle East And Africa
- 8.1.1 Uae
- 8.1.2 Saudi Arabia
- 8.1.3 Kuwait
- 8.1.4 South Africa
- 8.1.5 Rest Of Middle East And Africa
- 9 Middle East And Africa Drug Safety Solutions & Pharmacovigilance Market, Company Landscape
- 9.1 Company Share Analysis: Middle East And Africa
- 10 Company Profile
- 10.1 Syneos Health
- 10.1.1 Company Snapshot
- 10.1.2 Revenue Analysis
- 10.1.3 Company Share Analysis
- 10.1.4 Solution Portfolio
- 10.1.5 Recent Development
- 10.2 Covance Inc. (A Subsidiary Of Labcorp)
- 10.2.1 Company Snapshot
- 10.2.2 Revenue Analysis
- 10.2.3 Company Share Analysis
- 10.2.4 Service Portfolio
- 10.2.5 Recent Developments
- 10.3 Cognizant
- 10.3.1 Company Snapshot
- 10.3.2 Revenue Analysis
- 10.3.3 Company Share Analysis
- 10.3.4 Solution Portfolio
- 10.3.5 Recent Development
- 10.4 Accenture
- 10.4.1 Company Snapshot
- 10.4.2 Revenue Analysis
- 10.4.3 Company Share Analysis
- 10.4.4 Service Portfolio
- 10.4.5 Recent Developments
- 10.5 Parexel International Corporation
- 10.5.1 Company Snapshot
- 10.5.2 Product Portfolio
- 10.5.3 Recent Developments
- 10.6 Oracle
- 10.6.1 Company Snapshot
- 10.6.2 Revenue Analysis
- 10.6.3 Solution Portfolio
- 10.6.4 Recent Development
- 10.7 Ab Cube
- 10.7.1 Company Snapshot
- 10.7.2 Solution Portfolio
- 10.7.3 Recent Development
- 10.8 Arismiddle East And Africa
- 10.8.1 Company Snapshot
- 10.8.2 Product Portfolio
- 10.8.3 Recent Developments
- 10.9 Bioclinica
- 10.9.1 Company Snapshot
- 10.9.2 Service Portfolio
- 10.9.3 Recent Developments
- 10.10 C3i
- 10.10.1 Company Snapshot
- 10.10.2 Revenue Analysis
- 10.10.3 Service Portfolio
- 10.10.4 Recent Developments
- 10.11 Drug Safety Solutions Limited
- 10.11.1 Company Snapshot
- 10.11.2 Service Portfolio
- 10.11.3 Recent Development
- 10.12 Ennov
- 10.12.1 Company Snapshot
- 10.12.2 Product Portfolio
- 10.12.3 Recent Developments
- 10.13 Ergomed Plc
- 10.13.1 Company Snapshot
- 10.13.2 Revenue Analysis
- 10.13.3 Service Portfolio
- 10.13.4 Recent Developments
- 10.14 Genpact
- 10.14.1 Company Snapshot
- 10.14.2 Revenue Analysis
- 10.14.3 Product Portfolio
- 10.14.4 Recent Developments
- 10.15 Icon Plc
- 10.15.1 Company Snapshot
- 10.15.2 Revenue Analysis
- 10.15.3 Service Portfolio
- 10.15.4 Recent Developments
- 10.16 Iqvia
- 10.16.1 Company Snapshot
- 10.16.2 Revenue Analysis
- 10.16.3 Solution Portfolio
- 10.16.4 Recent Developments
- 10.17 Pharmaceutical Product Development, Llc.
- 10.17.1 Company Snapshot
- 10.17.2 Service Portfolio
- 10.17.3 Recent Developments
- 10.18 Pharmaceutical Research Associates Inc.
- 10.18.1 Company Snapshot
- 10.18.2 Revenue Analysis
- 10.18.3 Solution Portfolio
- 10.18.4 Recent Developments
- 10.19 United Biosource Llc
- 10.19.1 Company Snapshot
- 10.19.2 Service Portfolio
- 10.19.3 Recent Development
- 10.20 Worldwide Clinical Trials
- 10.20.1 Company Snapshot
- 10.20.2 Service Portfolio
- 10.20.3 Recent Developments
- 11 Questionnaire
- 12 Related Reports